Skip to main content

Table 2 Comparison of laboratory test results among three groups

From: Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy

  Complication Group
(n = 82)
Diabetes Group
(n = 85)
Healthy Control Group
(n = 90)
χ2/t P
FPG (mmol/L) 12.45 ± 1.29a,b 9.39 ± 1.04b 5.39 ± 0.87 936.87 <0.001
HbA1C (%) 9.81 ± 0.17b 9.01 ± 0.26b 5.56 ± 0.54 3328.435 <0.001
TC (mmol/L) 4.78 ± 1.17 4.69 ± 1.12 4.39 ± 1.02 2.988 0.052
TG (mmol/L) 2.38 ± 0.13b 2.33 ± 2.08b 1.79 ± 0.37 6.315 0.002
HDL-C (mmol/L) 1.17 ± 0.41 1.11 ± 0.37 1.03 ± 0.37 2.897 0.057
LDL-C (mmol/L) 3.02 ± 0.98 2.85 ± 0.91 2.76 ± 0.91 1.704 0.184
CRP (mg/mL) 6.78 ± 0.47a,b 3.45 ± 0.21b 2.49 ± 0.24 4071.146 <0.001
IL-6 (pg/mL) 123.93 ± 30.93a,b 80.99 ± 12.39b 64.39 ± 8.73 209.132 <0.001
Visfatin (pg/mL) [M (QL,QU)] 667.93 (340.83,1093.89)a,b 372.79 (334.93,470.93)* 358.73 (332.98,428.71) 183.09 <0.001
JAZFl (pg/mL) [M (QL,QU)] 122.29 (86.39,253.29)a,b 153.39 (132.91,203.29)b 221.92 (204.92,341.92) 208.11 <0.001
FIns (μIU/mL) 12.09 ± 1.21b 12.06 ± 1.34b 15.41 ± 2.01 131.363 <0.001
HOMA-IR 6.54 ± 0.37a,b 4.62 ± 0.36b 3.56 ± 0.32 1586.769 <0.001
EAT thickness (mm) 5.58 ± 1.23a,b 3.58 ± 0.78b 2.71 ± 0.54 233.854 <0.001
baPWV 1698.23 ± 227.89a,b 1607.46 ± 236.41a,b 1320.28 ± 112.13 96.625 < 0.001
  1. FPG fasting plasma glucose, HbA1C hemoglobin A1C, TC total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, CRP C-reactive protein, IL-6 interleukin-6, FIns fasting insulin, HOMA-IR homeostasis model assessment of insulin resistance, EAT epicardial adipose tissue
  2. acompare with Diabetes Group (P<0.05); bcompare with Healthy Control Group (P<0.05)
\